Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2020
An Embolic Stroke in a Patient With PROC p.Lys193del.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ueki Kana, Nakamura Kuniyuki, Wakisaka Yoshinobu, Wada Shinichi, Yoshikawa Yoji, Matsumoto Shinya, Hotta Taeko, Kang Dongchong, Kitazono Takanari, Ago Tetsuro
Аннотация
We report a 58-year-old woman who suddenly developed brain infarction with weakness of the left lower extremity and left perioral dysesthesia during postoperative tamoxifen therapy for breast cancer and prednisolone therapy for rheumatoid arthritis. Diffusion-weighted images detected multiple areas of hyperintensity in the posterior circulation system of the brain. Despite extensive examinations, we could not identify any embolic sources except hypoplasia of the right vertebral artery. We found decreased activity of protein C against its antigen level (activity: 59% versus antigen: 122%) with enhanced activity of coagulation factor VIII (178%) and von Willebrand factor (285%). DNA sequencing identified trinucleotide deletion of the PROC gene leading to 1 amino acid deletion at Lys-193 (p.Lys193del). We speculate that the PROC gene polymorphism may have participated in tamoxifen- and prednisolone- associated hypercoagulable state, leading to development of an embolic stroke in this patient.
Предметные рубрики MeSH
AnticoagulantsAntineoplastic Agents, HormonalBlood CoagulationFemaleGenetic Predisposition to DiseaseGlucocorticoidsHumansIntracranial EmbolismMethylprednisoloneMiddle AgedNeuroprotective AgentsPhenotypeProtein CProtein C DeficiencyRecurrenceRisk FactorsSequence DeletionStrokeTamoxifenTreatment Outcome